Ambit Finvest and Central Bank of India announce strategic co-lending partnership

Ambit Finvest Pvt. Ltd. (Ambit Finvest), the Non-Banking Financial Company (NBFC) of the Ambit Group, announced a co-lending arrangement with the Central Bank of India to offer MSMEs loans.   RBI’s Co-lending framework embodies a collaborative approach that harnesses the complementary strengths of banks and NBFCs to bolster lending in the priority sector.   Sanjay […]

Continue Reading

Time for a Change: pTron’s ‘Reflect Callz’ is Setting a New Pace in Smart, Affordable Wearables! — Made in India, Made for You!

·         The Reflect Callz comes with 1.85″ fully immersive touch HD display, 600 nits display brightness making the watch UI screen highly visible in bright outdoor environments.   ·         The smartwatch with advanced Bluetooth calling function and a robust full-suite health tracking feature is priced at Rs 899/- for the launch and is available starting […]

Continue Reading

Tata Capital Unveils Next-Gen API Financial Solutions

In today’s dynamic and evolving digital landscape, Tata Capital Limited has launched a user-friendly API (Application Programming Interface) ecosystem for both retail and corporate clients. Through this, businesses can co-create solutions tailored to their unique needs to drive efficiency and productivity. This ecosystem will simplify the process of digital collaborations for partners and help them […]

Continue Reading

Netflix and Yash Raj Films Come Together to forge iconic partnership and defines a new era of storytelling in India

    India’s most legendary storytellers, Yash Raj Films (YRF), are coming together with the world’s leading streamer, Netflix to form a new multi-year creative partnership. The two iconic entertainers will collaborate to create films and series to bring defining stories to audiences in India and across the world.   The first project to come […]

Continue Reading

A Game-Changer in Liver Cancer Management: Atezolizumab-Bevacizumab Combination Extends Liver Cancer Patients’ Survival, Promises New Era in Treatment

With Atezolizumab-Bevacizumab combination median overall survival was 12 months  In patients with good liver function, survival was 21 months   A first-of-its-kind study in real world setting conducted in India by Asian Institute of Gastroenterology (AIG) and published in the Journal of Clinical and Experimental Hepatology showed immunotherapy Atezolizumab-bevacizumab combination as a breakthrough in liver cancer treatment with a significant number of […]

Continue Reading